Pretreatment Inflammatory Indices as Predictors of Survival in Endometrial Cancer: A Retrospective Cohort Study From Mexico
Pre-treatment inflammatory indices, particularly LMR, are promising prognostic biomarkers for OS in endometrial cancer, offering accessible tools for risk stratification in low-middle-income settings. These indices should not replace established clinical prognosticators but may provide additive value. Prospective, multicenter studies are needed to confirm these findings and integrate them into clinical practice.
Authors
- Rosa A. Salcedo‐Hernández (ORCID: https://orcid.org/0000-0003-4537-8034)
- Cintia María Sepúlveda-Rivera
- Salim Barquet-Muñoz (ORCID: https://orcid.org/0000-0002-3950-157X)
- Delia Pérez‐Montiel (ORCID: https://orcid.org/0000-0002-9338-2284)
- David Cantú de León (ORCID: https://orcid.org/0000-0002-0229-7931)
- Pamela Martínez-Alpizar
- Pamela Rico-Mejía
- Sebastian Duno-Caldera
Institutions
- Instituto Nacional de Perinatología (MX)
- Instituto Nacional de Cancerología (MX)
Publication Details
- Journal
- Cureus
- Published
- 2025-08-12
- DOI
- https://doi.org/10.7759/cureus.89855
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00